(Photo: Anna Shvets / Pexels )
Researchers at the Montreal Heart Institute have started selecting people above the age of 40 who test positive for COVID-19 to study the impact of the drug Colchicine on treating complications of the deadly virus.
Colchicine, an orally administered anti-inflammatory drug, was first used as early as 1500 BC in the form of autumn crocus, (a toxic autumn-blooming flowering plant) to treat joint swelling.
Nowadays the powerful medication is approved in the treatment of gout, Behçet’s disease, pericarditis and familial Mediterranean fever.
The clinical study, will evaluate the impact of the widely available inexpensive drug in treating complications of COVID-19.
Knowing what to look for is important, so people can get support to help them…
Image: Laura James With 10,000 healthcare workers already off the job amid the sixth wave of pandemic…
Photo: Anete Lusina If your employer invites you to attend a meeting, you MUST ask…
The C.D.C. also affirmed there is no need to quarantine at home following high-risk exposures…
Hospital executives who have hired Litvak describe him as a genius and a pioneer in…
Photo cottonbro / Pexels Many people focus on worst-case scenarios in the days following the…
This website uses cookies.